These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12140583)

  • 21. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
    Spuls PI; Hooft L
    Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H; Polson RJ
    Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori infection and dyspepsia.
    Armstrong D
    Scand J Gastroenterol Suppl; 1996; 215():38-47. PubMed ID: 8722381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Functional Dyspepsia and infection by Helicobacter pylori: a causal relation does not exist].
    López Gastón A; Andrusch A; Catuogno P
    Acta Gastroenterol Latinoam; 2003; 33(1):13-21. PubMed ID: 14708506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment.
    See MC; Birnbaum AH; Schechter CB; Goldenberg MM; Benkov KJ
    Dig Dis Sci; 2001 May; 46(5):985-92. PubMed ID: 11341669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
    Ng FH; Wong SY; Lam KF; Chu WM; Chan P; Ling YH; Kng C; Yuen WC; Lau YK; Kwan A; Wong BC
    Gastroenterology; 2010 Jan; 138(1):82-8. PubMed ID: 19837071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
    McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T
    N Engl J Med; 1998 Dec; 339(26):1869-74. PubMed ID: 9862941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia.
    Ogutu EO; Kang'ethe SK; Nyabola L; Nyong'o A
    East Afr Med J; 1998 Feb; 75(2):85-9. PubMed ID: 9640829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diet and drugs in the therapy of nonorganic dyspepsia: the hypothesis and factual data].
    Dobrilla G; Zancanella I; Benvenuti S; Comberlato M; Amplatz S; Di Fede F; De Guelmi A
    Minerva Gastroenterol Dietol; 1996 Jun; 42(2):71-82. PubMed ID: 8962908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-ulcer dyspepsia: myths and realities.
    Talley NJ
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():145-62. PubMed ID: 1888833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Famotidine in the treatment of functional dyspepsia: a randomized double-blind, placebo-controlled trial.
    Amini M; Ghamar Chehreh ME; Khedmat H; Valizadegan G; Babaei M; Darvishi A; Taheri S
    J Egypt Public Health Assoc; 2012 Apr; 87(1-2):29-33. PubMed ID: 22415333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sucralfate versus placebo in treatment of non-ulcer dyspepsia.
    Kairaluoma MI; Hentilae R; Alavaikko M; Kellosalo J; Stahlberg M; Jalovaara P; Olsen M; Jaervensivu P; Laitinen S
    Am J Med; 1987 Sep; 83(3B):51-5. PubMed ID: 3310629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatric disorder in essential dyspepsia.
    Kumar S; Khannar R; Hajra B; Bose J
    Int J Psychiatry Clin Pract; 1998; 2(1):41-5. PubMed ID: 24946246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative study of the effectiveness of cimetidine, ranitidine, famotidine, and omeprazole in treatment of children with dyspepsia.
    Dehghani SM; Imanieh MH; Oboodi R; Haghighat M
    ISRN Pediatr; 2011; 2011():219287. PubMed ID: 22389770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in serum ghrelin level in relation to meal-time in patients with functional dyspepsia.
    Kazemi M; Eshraghian A; Hamidpour L; Taghavi S
    United European Gastroenterol J; 2015 Feb; 3(1):11-6. PubMed ID: 25653854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of preanesthetic famotidine on gastric volume and pH.
    Okuda T; Takatsu T; Kumode O; Shiokawa Y; Suekane K
    J Anesth; 1988 Mar; 2(1):17-21. PubMed ID: 15235828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Tolerability of Famotidine in Preventing Heartburn and Related Symptoms of Upper Gastrointestinal Discomfort.
    Gottlieb S; Decktor DL; Eckert JM; Simon TJ; Stauffer L; Ciccone PE
    Am J Ther; 1995 May; 2(5):314-319. PubMed ID: 11850669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.